Research Topics
Species | Bin S TehSummaryAffiliation: The Methodist Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinomaYu Feng Ren
State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat Sen University, Guangzhou, PRC
Radiat Oncol 5:113. 2010....
[Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond]Bin S Teh
Department of Radiation Oncology, The Methodist Hospital, The Methodist Hospital Research Institute, Houston, TX 77030, USA
Ai Zheng 27:885-93. 2008..Cancer stem cell, gene expression profiling and nanotechnology with the implications on radio-resistance are new exciting areas requiring more research in future as we move toward personalized medicine...- Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sitesBin S Teh
Department of Radiation Oncology, Radiology, and Genito urinary Oncology, The Methodist Hospital, The Methodist Hospital Research Institute and Baylor College of Medicine, 6565 Fannin St MS 121 B, Houston, TX 77030, USA
Technol Cancer Res Treat 6:347-54. 2007.... - Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh
Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 59:562-71. 2004..The addition of radiotherapy to in situ gene therapy seems to further increase the total CD8+ T cells and activated CD4+ T cells... - Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost techniqueChad M Amosson
Department of Radiology/Section of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:136-44. 2003..This is feasible even with an accelerated treatment regimen like the SMART boost. More patients need to be evaluated using IMRT to identify relevant dosimetric parameters... - Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy dataBin S Teh
Department of Radiology, Baylor College of Medicine, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 58:1520-9. 2004..We now report the prostate-specific antigen (PSA) response and biopsy data... - Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancerBin S Teh
Department of Radiology Section of Radiation Oncology, Baylor College of Medicine, The Methodist Hospital, Houston, TX 77030, USA
Med Dosim 30:25-30. 2005..The findings have clinical significance for future very high-dose escalation trials whereby radiation proctitis is a major limiting factor... - Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patientsTetsuo Fujita
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 65:84-90. 2006..Prolonged use of hormonal therapy does not suppress this response. These results suggest the potential for sustained activation of cell-mediated immune responses against cancer... - Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancerGustavo Ayala
Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Mol Ther 13:716-28. 2006..Increased apoptosis and decreased microvessel density were also noted in these patients. The results suggest a tumor-specific effect mediated by systemic and local immune response, antiangiogenic effect, and modulation of apoptosis... - The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?Bin S Teh
Department of Radiology Section of Radiation Oncology, Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA
Cancer J 8:476-83. 2002..The purpose of this study was to investigate the role of a rectal balloon for prostate immobilization and rectal toxicity reduction in patients receiving dose-escalated intensity-modulated radiotherapy for prostate cancer... - The evolution of quality assurance for intensity- modulated radiation therapy (IMRT): sequential tomotherapyShiao Y Woo
Baylor College of Medicine, The Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:274-86. 2003.... - Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor controlBin S Teh
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, Methodist Hospital, Houston, TX, USA
Cancer Invest 20:437-51. 2002..Tumor response, local control, and the ability to palliate previously irradiated patients are encouraging. Intensity modulated radiation therapy will allow dose escalation, leading to better tumor control... - IMRT for prostate cancer: defining target volume based on correlated pathologic volume of diseaseBin S Teh
Department of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:184-91. 2003.... - Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilizationBin S Teh
Department of Radiology Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
Med Dosim 27:105-13. 2002..Overall, toxicity profiles in these patients were very favorable. IMRT has the potential to improve treatment outcome with dose escalation while minimizing treatment-related toxicity... - Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff
Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, ST 2100, Houston, Texas 77030, USA
Technol Cancer Res Treat 5:23-36. 2006..The combined approach maximizes tumor control, both local-regional and systemic through radio-genetherapy induced cytotoxicity and anti-tumor immunity... 
The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningiomaArnold C Paulino
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 75:1408-14. 2009..To identify pretreatment characteristics and radiotherapy parameters which may influence time interval to development of radiation-associated meningioma (RAM)...- Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRTSalahuddin Ahmad
Department of Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA
Med Dosim 30:1-7. 2005..Setup uncertainty had minimum impact on target dose escalation and normal tissue dosing. The impact of target dose inhomogeneity is currently evaluated in clinical studies... - Dose response and local control using radiotherapy in non-metastatic Ewing sarcomaArnold C Paulino
Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, Texas, USA
Pediatr Blood Cancer 49:145-8. 2007..To determine prognostic factors for local control in the radiotherapeutic management of non-metastatic Ewing sarcoma... - Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastomaArnold C Paulino
Department of Radiation Oncology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 78:1445-50. 2010.... - A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastasesPavan M Jhaveri
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, 6565 Fannin, Houston, TX 77030, USA
Acta Oncol 51:584-8. 2012..To investigate the utility of stereotactic body radiotherapy (SBRT) in the treatment of painful renal cell carcinoma (RCC) bone metastases, and for a possible dose effect on time to symptom relief... - Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastomaArnold C Paulino
Department of Radiation Oncology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, Texas, USA
Cancer 117:635-41. 2011..The current study was conducted to determine whether the use of cochlear-sparing intensity-modulated radiotherapy (IMRT) boost results in excess local failures in children with medulloblastoma... - Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiformeNathan S Floyd
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 58:721-6. 2004..Future investigation may be useful to determine which fraction size may be optimal for GBM when highly conformal RT is used in the adjuvant setting... - Stereotactic body radiation therapy: a novel treatment modalitySimon S Lo
Department of Radiation Oncology, Arthur G James Cancer Hospital, Ohio State University College of Medicine, 300 West 10th Avenue, Columbus, OH 43210, USA
Nat Rev Clin Oncol 7:44-54. 2010..The results of these clinical trials will better define the role of SBRT in cancer management. This article will review the radiobiologic, technical, and clinical aspects of SBRT... - Outcome of patients with pilocytic astrocytoma and leptomeningeal disseminationAli Mazloom
Department of Radiation Oncology, Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 84:350-4. 2012..To determine the patient, tumor, and treatment characteristics of patients with pilocytic astrocytoma (PA) and leptomeningeal dissemination (LMD)... - Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomyBin S Teh
Department of Radiology Section of Radiation Oncology, Methodist Hospital and Baylor College of Medicine, Houston, TX 77030, USA
Am J Clin Oncol 30:395-400. 2007..A sural nerve graft may replace a killed cavernosal nerve. The effect of intensity-modulated radiation therapy (IMRT) on function of the graft has not been reported... - Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcomaAmarinthia E Curtis
Section of Radiation Oncology, Department of Radiology, Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 73:173-7. 2009..To examine the patterns of failure in patients treated with intensity-modulated radiotherapy (IMRT) for head-and-neck rhabdomyosarcoma (RMS)... - Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapyChad M Amosson
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
Semin Oncol 29:71-9. 2002..The purpose of this article is to evaluate the significance of parotid gland dosimetry in relation to subjective salivary gland function... - Stereotactic body radiation therapy for prostate cancerHiromichi Ishiyama
Department of Radiation Oncology, The Methodist Hospital and Research Institute, Houston, TX 77030, USA
Future Oncol 7:1077-86. 2011..The purpose of this article is to examine radiobiological, technical and clinical aspects of SBRT for prostate cancer... - Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgeryBin S Teh
Department of Radiology, Section of Radiation Oncology, The Methodist Hospital, Houston, Texas 77030, USA
Cancer J 9:454-60. 2003..In this study, we attempted to find predictors of extracapsular extension (ECE) and its radial distance... - Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancerMichael D Bastasch
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, Houston, TX, USA
Am J Clin Oncol 29:8-11. 2006..Duration of the toxicities typically was 1 to 2 weeks. Patients with pre-existing anorectal disease are at higher risk of developing acute anorectal toxicity with the use of an endorectal balloon... - Intensity-modulated radiation therapy in childhood ependymomaThomas M Schroeder
Department of Radiation Oncology, University of New Mexico Cancer Center, The University of New Mexico, Albuquerque, NM, USA
Int J Radiat Oncol Biol Phys 71:987-93. 2008..To determine the patterns of failure after intensity-modulated radiation therapy (IMRT) for localized intracranial ependymoma... - Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgeryBin S Teh
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
Clin Genitourin Cancer 5:334-7. 2007..This finding also provides a rationale to deliver stereotactic body RT for primary and metastatic RCC extracranially. A prospective clinical trial using stereotactic body RT for primary and metastatic RCC is under way... - Radiation proctopathy in the treatment of prostate cancerAmit K Garg
Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 66:1294-305. 2006..With further study of possible risk factors, the advent of a standardized grading scale, and more randomized trials to evaluate treatments, patients and physicians will be better armed to make appropriate management decisions... - Radiation therapy in the management of brain metastases from renal cell carcinomaLucius S Doh
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, The Methodist Hospital, Houston, Texas 77030, USA
Oncology (Williston Park) 20:603-13; discussion 613, 616, 619-20 passsim. 2006..Newer radiosensitizers (eg, motexafin gadolinium [Xcytrin]) and chemotherapeutic agents (eg, temozolomide [Temodar]) used in combination with radiotherapy will also be discussed... - Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patientsEugene Huang
Baylor College of Medicine, Houston, Tex 77030, USA
Stereotact Funct Neurosurg 79:44-50. 2002.... - Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile functionMichael D Bastasch
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and Methodist Hospital, 6565 Fannin, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 54:101-6. 2002..Longer term follow-up and a larger cohort of patients are warranted to confirm these findings... - Imaging changes after stereotactic body radiation therapy for lung and liver tumorsSimon S Lo
Department of Radiation Oncology, University Hospitals Case Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Lerner Tower B181, Cleveland, OH 44106, USA
Expert Rev Anticancer Ther 11:613-20. 2011..Since computed tomography and PET are the most commonly used diagnostic imaging tools for monitoring lung tumor and computed tomography for liver tumors, this article will focus on the changes observed on those imaging modalities... - Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphomaArnold C Paulino
Department of Radiation Oncology, The Methodist Hospital, The Methodist Hospital Research Institute, Houston, TX, USA
Pediatr Blood Cancer 58:860-4. 2012..To determine how the incorporation of PET-CT changes radiotherapy treatment in pediatric Hodgkin lymphoma... - Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancerBin S Teh
Baylor College of Medicine, Houston, Texas 77030, USA
Oncologist 7:458-66. 2002..This approach also offers a new paradigm in spatial cooperation, whereby two local therapies are combined to elicit both local and systemic effects. Early clinical results showed the safety of this approach... - Intensity-modulated radiation therapy (IMRT) for meningiomaNathan W Uy
Department of Radiology/Section of Radiation Oncology, The Methodist Hospital and Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 53:1265-70. 2002..Toxicity data are encouraging, but the potential for serious side effects exists, as demonstrated by one possible treatment-related death. Larger cohort and longer follow-up are needed to better define efficacy and late toxicity of IMRT... - Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical marginsBin S Teh
Department of Radiology Section of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA
J Urol 175:2097-101; discussion 2101-2. 2006..In this retrospective study we define the benefits of elective postoperative radiotherapy in this setting... - Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist HospitalMichael South
Department of Radiation Oncology, Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:477-83. 2008..The advantages of the supine position for craniospinal irradiation include patient comfort, easier access to maintain an airway for anesthesia, and reduced variability of the head tilt in the face mask... - Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgeryMarianna Karpinos
Department of Radiology/Section of Radiation Oncology, Baylor College of Medicine, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 54:1410-21. 2002..Radiosurgery yields better measurable hearing preservation than microsurgery and equivalent serviceable hearing preservation rate and tumor growth control... - Treatment trends and outcomes of small-cell carcinoma of the bladderEugene J Koay
Baylor College of Medicine, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 83:64-70. 2012..Treatment for small-cell carcinoma of the bladder is largely guided by case reports, retrospective reviews, and small prospective trials. This study aimed to study outcomes using a large population-based database... - Emerging applications of stereotactic body radiation therapy for head and neck cancerFarzan Siddiqui
Arthur G James Cancer Hospital, Ohio State University Medical Center, Department of Radiation Oncology, 300 West 10th Avenue, Columbus, OH 43210, USA
Expert Rev Anticancer Ther 11:1429-36. 2011..This article will highlight some of the technical and clinical advances in this area... - Stereotactic body radiotherapy in the management of painful bone metastasesPavan Jhaveri
Department of Radiology, Baylor College of Medicine, Houston, TX 77030, USA
Oncology (Williston Park) 22:782-8; discussion 788-9, 796-7. 2008..Toxicity to surrounding normal tissues and patterns of local failures are also addressed... - Therapeutic targets for metastatic prostate cancerTerry L Timme
Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
Curr Drug Targets 4:251-61. 2003.... - Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis systemHadi Zahra
Radiology Radiation Oncology, Baylor College of Medicine, One, Baylor Plaza, Houston, TX 77030, USA
Technol Cancer Res Treat 8:407-12. 2009..This information is important as more centers are obtaining image-guided stereotactic-based linear accelerators capable of performing radiosurgery... - A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostateRobert J Amato
Genitourinary Oncology Program, The Methodist Hospital Research Institute, Houston, TX 77030, USA
Urol Oncol 27:165-9. 2009..A retrospective review was conducted to evaluate results... - Stereotactic body radiation therapy (SBRT) for genitourinary malignanciesBin S Teh
Department of Radiation Oncology, The Methodist Hospital, Houston, Texas 77030, USA
Discov Med 10:255-62. 2010..Preclinical data, clinical experience, and challenges are reviewed and discussed... - Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancerCourtney Sheinbein
Department of Radiology Radiation Oncology, Baylor College of Medicine, Houston, Texas, USA
Urology 76:728-33. 2010..Previous studies have reported PSA bounce in prostate cancer patients treated with conventional radiotherapy, 3D conformal radiotherapy, and permanent seed brachytherapy... - Prostate adenocarcinoma presenting with inguinal lymphadenopathyEugene Huang
Department ofRadiology/Section of Radiation Oncology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
Urology 61:463. 2003..We present a case of prostate adenocarcinoma with inguinal node involvement during the initial presentation, emphasizing the importance of a complete physical examination and the consideration of other concurrent diseases... - Stereotactic body radiation therapy for oligometastasesSimon S Lo
Department of Radiation Oncology, Arthur G James Cancer Hospital, Ohio State University, Columbus, Ohio 43210, USA
Discov Med 10:247-54. 2010..Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored... - Radiation-induced malignant gliomas: is there a role for reirradiation?Arnold C Paulino
Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:1381-7. 2008..To review the literature regarding the role of radiotherapy (RT) in the treatment of patients with radiation-induced malignant gliomas (RIMGs)... - Rhabdomyosarcoma arising in a previously irradiated field: an analysis of 43 patientsNguyen D Dang
Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 85:598-603. 2013..002). Age at time of RMS-RIF, retinoblastoma initial tumor, favorable site, stage 1 disease, and use of both systemic and local treatment were found to be favorable prognostic factors for 3-year overall survival... - The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivoYuanhong Gao
Department of Radiation Oncology, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, TX 77030, USA
Radiat Oncol 6:39. 2011..In this study, we investigated the effect of the combined treatment of perifosine and radiation (CTPR) on prostate cancer cells in vitro and on prostate cancer xenografts in vivo... - Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemiaArnold C Paulino
Department of Radiation Oncology, The Methodist Hospital, The Methodist Hospital Research Institute, Houston, Texas 77030, USA
Pediatr Blood Cancer 56:279-81. 2011..The purpose of this study is to determine whether height measurements are affected by cranial radiation doses of 12-18 Gy... - Standardization of head and neck contouring using the acanthiomeatal lineSnehal Desai
Baylor College of Medicine, Department of Radiology, Section of Radiation Oncology, Houston, TX 77030, USA
Med Dosim 34:225-7. 2009..This will simplify contouring on axial computed tomography (CT) images of the neck. Standardizing the chin position is an important step to developing a standardized atlas and developing an information tool for automated contouring... - HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virusSuleiman Massarweh
Department of Medicine, Division of Oncology Hematology, Ben Taub General Hospital, Baylor College of Medicine, Houston, Texas 77030, USA
Am J Hematol 72:216-9. 2003..Extranodal presence of Hodgkin's disease in patients with HIV infection is probably related to immunosuppression, and physicians treating this illness should be alert to the potential of unusual sites of involvement... - Rare case of metastatic prostate adenocarcinoma to the pituitaryNilesh Patel
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
Urology 62:352. 2003..The patient responded well to radiotherapy. The mechanisms of spread to the pituitary gland and treatment options, including intensity-modulated radiotherapy, are discussed... - Computer visualization techniques (CVTs) foster evidence-based target delineationE Brian Butler
Department of Radiation Oncology, The Methodist Hospital, Houston, Texas, USA
Cancer Invest 25:1-5. 2007..This ability to standardize strategies will allow the collection of meaningful evidence based outcome data... - Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinomaEugene Huang
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
Urology 60:1111. 2002..Various aspects of the radiographic imaging, evaluation of elevated prostate-specific antigen, and treatment of prostate adenocarcinoma are discussed... - Radiation-induced moyamoya syndromeSnehal S Desai
Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Methodist Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 65:1222-7. 2006..Patients with NF-1 have a lower radiation-dose threshold for development of moyamoya syndrome... - Role of radiation therapy in a patient with primary pancreatic lymphomaKaren H Shahar
Department of Radiology, Section of Radiation Oncology, Baylor College of Medicine and The Methodist Hospital, 6565 Fannin, Houston, TX 77030, USA
Clin Lymphoma Myeloma 6:143-5. 2005..The role of radiation therapy as an adjunct to chemotherapy for the treatment of this disease is poorly defined. We present a case of primary pancreatic lymphoma treated with radiation therapy as an adjunct to chemotherapy... - Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancerAngela Shoher
Department of Surgery, Baylor College of Medicine, and The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402, USA
Curr Surg 63:207-12. 2006..Drainage to extraaxillary sites was rare. LS findings did not enhance success of intraoperative identification of SN or alter the postoperative management of patients with early stage breast cancer... - Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicityEugene Huang
Department of Radiology/Section of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
Int J Radiat Oncol Biol Phys 52:599-605. 2002..Our findings suggest that, despite higher doses of cisplatin, and despite radiotherapy before cisplatin therapy, treatment with IMRT can achieve a lower rate of hearing loss... - Radiation-induced osteosarcomas in the pediatric populationMatthew Koshy
Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 63:1169-74. 2005..CONCLUSION: The type of treatment for R-OS was the most significant factor for cause-specific and overall survival. Patients who develop R-OS should be aggressively treated, because the outcome is not as dismal as once thought... - Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glandsJonathan Verma
Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA
Pediatr Blood Cancer 57:1137-41. 2011..The purpose of our study is to review the patient, tumor, and treatment characteristics of patients who develop a treatment-related MEC... - Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case reportYee Lu Tham
Breast Care Center, Baylor College of Medicine, Houston, TX 77030, USA
Clin Breast Cancer 7:164-6. 2006..The significance of persistent circulating tumor cells in the CNS in patients without evidence of disease is unclear but should be investigated further... - Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinomaTai-Xiang Lu
Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, People's Republic of China
Int J Radiat Oncol Biol Phys 58:682-7. 2004..More patients and longer term follow-up are warranted to evaluate late toxicity and treatment outcome... - Treatment of brain tumorsArnold C Paulino
N Engl J Med 352:2350-3; author reply 2350-3. 2005 - Renal-cell carcinomaLucius Doh
N Engl J Med 354:1095-6; author reply 1095-6. 2006